Diamyd Medical AB (DYMDF)
0.73
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Diamyd Medical EPS Diluted (Quarterly) : -0.0909 for May 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.0909 |
| February 28, 2026 | -0.05 |
| November 30, 2025 | -0.0376 |
| August 31, 2025 | -0.0341 |
| May 31, 2025 | -0.0421 |
| February 28, 2025 | -0.0392 |
| November 30, 2024 | -0.0334 |
| August 31, 2024 | -0.0473 |
| May 31, 2024 | -0.0387 |
| February 29, 2024 | -0.0296 |
| November 30, 2023 | -0.0341 |
| August 31, 2023 | -0.0244 |
| May 31, 2023 | -0.0256 |
| February 28, 2023 | -0.0303 |
| November 30, 2022 | -0.0382 |
| August 31, 2022 | -0.0452 |
| May 31, 2022 | -0.0223 |
| February 28, 2022 | -0.0124 |
| November 30, 2021 | -0.0585 |
| August 31, 2021 | -0.0434 |
| May 31, 2021 | -0.0542 |
| February 28, 2021 | 0.0254 |
| November 30, 2020 | 0.168 |
| August 31, 2020 | -0.021 |
| May 31, 2020 | -0.0102 |
| Date | Value |
|---|---|
| February 29, 2020 | 0.00 |
| November 30, 2019 | -0.0098 |
| August 31, 2019 | -0.0145 |
| May 31, 2019 | -0.0122 |
| February 28, 2019 | -0.0167 |
| November 30, 2018 | -0.0163 |
| August 31, 2018 | -0.0227 |
| May 31, 2018 | -0.0255 |
| February 28, 2018 | -0.0194 |
| November 30, 2017 | -0.0227 |
| August 31, 2017 | -0.0116 |
| May 31, 2017 | -0.0329 |
| February 28, 2017 | -0.0189 |
| November 30, 2016 | -0.0097 |
| August 31, 2016 | -0.0203 |
| May 31, 2016 | -0.0728 |
| February 29, 2016 | -0.0201 |
| November 30, 2015 | -0.0181 |
| August 31, 2015 | -0.0182 |
| May 31, 2015 | -0.0361 |
| February 28, 2015 | -0.0192 |
| November 30, 2014 | -0.0318 |
| August 31, 2014 | -0.0226 |
| May 31, 2014 | -0.0236 |
| February 28, 2014 | -0.0236 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hansa Biopharma AB | -0.279 |
| BioArctic AB | -0.0134 |
| Swedish Orphan Biovitrum AB | 0.1673 |
| BONESUPPORT HOLDING AB | 0.1309 |
| BioInvent International AB | -0.1995 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.67M |
| Revenue (Quarterly) | 0.0074M |
| Total Expenses (Quarterly) | 13.68M |
| Enterprise Value | 81.42M |
| Gross Profit Margin (Quarterly) | -32.07K% |
| Profit Margin (Quarterly) | -184.8K% |
| Earnings Yield | -29.12% |
| Normalized Earnings Yield | -29.03 |